Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure
Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Background and Methods:
Limited data are available on the safety of fingolimod in pregnant women. We estimated the risk of adverse pregnancy outcomes in women with multiple sclerosis (MS) exposed to fingolimod either shortly before or during pregnancy in prospectively collected cases from clinical trials, observational studies, surveillance prog...
Alternative Titles
Full title
Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_57cb7c7e00804159b2b87a51e9ad4360
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_57cb7c7e00804159b2b87a51e9ad4360
Other Identifiers
ISSN
1756-2864,1756-2856
E-ISSN
1756-2864
DOI
10.1177/1756286418804760
